NCT00804401View on ClinicalTrials.gov

Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

July 31, 2004

Conditions
Bioequivalency
Interventions
DRUG

Naproxen Tablets, 500 mg

All Listed Sponsors
lead

Perrigo Company

INDUSTRY

NCT00804401 - Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter